TJ Dillashaw relinquished his UFC bantamweight title championship Wednesday after the U.S. Anti-Doping Agency and the New York State Athletic Commission informed him of an “adverse analytical finding” in a drug test dating back to his most recent fight, in January in Brooklyn. The NYSAC issued him a one-year suspension and $10,000 fine. The decision leaves many questions for UFC fans, including where Dillashaw goes from here and the future of the bantamweight and flyweight divisions.
Here’s what you need to know based off Wednesday’s announcement.
What did TJ Dillashaw test positive for?
It is unclear at this time specifically what the “adverse analytical finding” was. According to USADA, it stems from an in-competition test conducted Jan. 18. Dillashaw headlined the first UFC card on ESPN+ on Jan. 19, a fight against flyweight champ Henry Cejudo in which he lost by first-round TKO.